We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.88%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.45B
AUM Growth
+$379M
(+7.5%)
Cap. Flow
+$62.7M
Cap. Flow
% of AUM
1.15%
Top 10 Holdings %
Top 10 Hldgs %
26.99%
Holding
161
New
18
Increased
65
Reduced
42
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Doximity
DOCS
|
+$43.7M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$39.4M |
| 3 |
Lithia Motors
LAD
|
+$30.5M |
| 4 |
Palo Alto Networks
PANW
|
+$25.7M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTM
ZoomInfo Technologies
GTM
|
+$82.3M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$41.8M |
| 3 |
Immunovant
IMVT
|
+$40M |
| 4 |
DoubleVerify
DV
|
+$35.4M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$34.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.08% |
| 2 | Technology | 23.47% |
| 3 | Industrials | 13.06% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Utilities | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Baxter International
BAX
$13.8B
| – | – |
-198,600
| Closed | -$10.1M |
|
|
BCYC
152
Bicycle Therapeutics
BCYC
$280M
| – | – |
-853,800
| Closed | -$25.3M |
|
153
Compass Therapeutics
CMPX
$349M
| – | – |
-935,091
| Closed | -$4.7M |
|
154
Devon Energy
DVN
$50.9B
| – | – |
-107,657
| Closed | -$6.62M |
|
155
EQT Corp
EQT
$33B
| – | – |
-206,291
| Closed | -$6.98M |
|
|
KALV
156
DELISTED
KalVista Pharmaceuticals
KALV
| – | – |
-276,200
| Closed | -$1.87M |
|
157
NXP Semiconductors
NXPI
$61.8B
| – | – |
-369
| Closed | -$58.3K |
|
158
Praxis Precision Medicines
PRAX
$8.58B
| – | – |
-234,537
| Closed | -$8.37M |
|
|
SNV
159
DELISTED
Synovus
SNV
| – | – |
-184,028
| Closed | -$6.91M |
|
160
Walker & Dunlop
WD
$1.68B
| – | – |
-94,535
| Closed | -$7.42M |
|
|
FRC
161
DELISTED
First Republic Bank
FRC
| – | – |
-132,371
| Closed | -$16.1M |
|
Similar funds
HPG
EMPI
RCG
JWBC
AAM
AA
CM
CIS
Eventide Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Eventide Asset Management held 161 positions worth $5.45B, up 7.5% from $5.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Eventide Asset Management's Q1 2023 filing shows 18 new, 65 increased, 42 reduced and 14 closed positions. Its largest new stake was Lithia Motors: 125,499 shares worth $28.7M. The largest sale was ZoomInfo Technologies, an estimated $82.3M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.
- Eventide Asset Management's largest Q1 2023 buy was Lithia Motors: 125,499 shares worth $28.7M.
- Eventide Asset Management added most to Doximity in Q1 2023, an estimated $43.7M increase.
- Eventide Asset Management's biggest Q1 2023 reduction was ZoomInfo Technologies, cutting an estimated $82.3M.
- Eventide Asset Management fully exited Bicycle Therapeutics in Q1 2023, selling an estimated $25.3M.
- Eventide Asset Management's ten largest holdings make up 27% of its $5.45B portfolio in Q1 2023.
- Eventide Asset Management opened 18 new positions and closed 14 in Q1 2023.
- Eventide Asset Management's portfolio value rose 7.5% quarter-over-quarter to $5.45B.
Based on Eventide Asset Management's 13F filing for Q1 2023, filed 15 May 2023.